hls

hls

Matt Becker 0
Three things you must do to create a central clinical platform

Collecting, managing, standardizing and analyzing clinical data during (and after) a clinical trial is crucial in the process for submission and regulatory approval of a new compound, biological, device or other therapy. A central clinical platform requires: Robust and auditable analytics to prove the result to the authorities and external

Robert Collins 0
Let SAS® Studio do your clinical research ‘tasks’

SAS is widely used in clinical research activities including: Managing and transforming data. Generating tabular and graphical summaries. Performing powerful statistical analyses such as safety and efficacy evaluations. In addition, SAS provides a number of interfaces from which a user can select to work with the data. One of these

Alan Cudney 0
Here comes MACRA: Analytics can help you measure and manage

Medicare payment changes are coming. The Centers for Medicare and Medicaid Services (CMS) has announced the intention of increasing the proportion of payments to providers based on outcomes and changes in health status, as opposed to delivery of services. At the January 11th, 2016 J.P. Morgan Annual Health Care Conference,

Krisa Tailor 0
2016: Revolutionizing the patient experience

Health care is undergoing exponential change, and this year we’ll continue to see the industry launch bold missions to improve the patient experience. With new types of data and technologies, the vision of making health care more personalized and proactive is becoming closer to reality. In my new book “The

Patrick Homer 0
The analytics-driven marketing evolution in life sciences

PharmaVOICE recently published an article: Analytics Driven Marketing for the pharmaceutical industry and I was fortunate enough to be interviewed. The article discusses the increased use of advanced analytics to make better marketing decisions, the progress that has been made and the challenges that still need to be overcome. Within

Paula Brown 0
Creating the care we deserve

Earlier this month I attended my first Forbes Healthcare Summit, where the stated goal for this year was to “figure out how to create the kind of care we know we deserve.” The event offered a unique gathering of pharmaceutical, health care and biotechnology chief executives engaged in frank discussions

Lee Shirkey 0
Health care spending waste? Analytics is the answer

We have all heard many times about how much the US spends on health care each year. But let’s hear it again . . .  because it is staggering: According to Centers for Medicare and Medicaid Services (CMS), in 2013, the national health expenditure (NHE) grew to $2.9 trillion. That

Patrick Homer 0
Maximize global revenue from pharmaceutical product launches

The high cost of pricing myopia When launching a pharmaceutical product, it’s not enough to negotiate the best reimbursable price for each local market. Overall financial performance will depend on successfully managing go-to-market strategies at the global level. That means determining the optimal price and launch sequence for all the

Peter Chingos 0
Moving to value-based health care with episodes of care

The move to value-based payments is well underway and accelerating. The shift is putting unprecedented pressure on health care providers to better manage the cost and quality of care they deliver. Who will have a much better shot of success? Organizations that understand how well they are performing, where they have opportunities to improve

Back to Top